explore -WSS

explore

author：leisure time 2025-08-23 05:04:35 - browse：99972

Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal — Adobe

A deal is never really done until it’s done.

On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Sanders adds drug shortage policies to pandemic preparedness bill

WSS

Cosmetics set for new safety regulation. Why the industry is on board

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

First over

$1 billion proposal to grow Boston, Massachusetts biotech

hotspot

explore

focus

Drug repurposing or repositioning? The language matters

Biden tests positive for Covid

After affirmative action ruling, medical educators look to 'holistic review'

AI can’t replace a physician’s gut feeling

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Sanofi seeks simpler, safer CRISPR sickle cell cure

Heart attack and stroke risk calculators need revising

A new approach to psychiatric drug development

Apple is now the first public company to be valued at $3 trillion

Medicare to cover more brain scans for Alzheimer’s patients

leisure time

Medicare drug price negotiation hearing pits pharma v Biden admin

Lack of health data on LGBTQ+ people has serious consequences

Listen: Wegovy in the brain & pivotal Alzheimer's data

As digital health tech proliferates, a new institute aims to cut through hype

Fetal cell organoids grown from amniotic fluid, study finds

Change Healthcare: What is it, why does its cyberattack matter?

leisure time

entertainment

hotspot

leisure time